6.52
price down icon0.09%   -0.006
after-market Dopo l'orario di chiusura: 6.70 0.18 +2.76%
loading

Immucell Corp Azioni (ICCC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
20.11%
6.4449
8.0672 7.7511 6.0116 5.4729
Cost Of Revenue
23.05%
3.627
4.7132 4.9195 4.428 4.2424
Gross Profit
15.98%
2.8179
3.354 2.8316 1.5836 1.2305
Operating Expenses
0.54%
2.2484
2.2363 2.2103 2.1584 2.6171
Benefits Costs and Expenses
10.23%
5.9411
6.6183 7.2305 6.7119 7.0032
Costs And Expenses
10.23%
5.9411
6.6183 7.2305 6.7119 7.0032
Operating Income/Loss
49.04%
0.5696
1.1176 0.6214 -0.5749 -1.3866
Nonoperating Income/Loss
119.86%
-0.0658
0.3313 -0.1008 -0.1255 -
Income/Loss From Continuing Operations Before Tax
65.23%
0.5038
1.4489 0.5206 -0.7004 -1.5303
Income Tax Expense/Benefit
0.00%
0.0019
0.0019 0.00604 0.00134 0.00134
Income/Loss From Continuing Operations After Tax
65.32%
0.5019
1.447 0.5146 -0.7017 -1.5316
Net Income/Loss
65.32%
0.5019
1.447 0.5146 -0.7017 -1.5316
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.56%
9.0313
8.9806 0.2588 8.1644 7.81
Diluted Average Shares
0.56%
9.0313
8.9806 0.2588 8.1644 7.81
Basic Earnings Per Share
62.50%
0.06
0.16 0.08 -0.09 -0.20
Diluted Earnings Per Share
62.50%
0.06
0.16 0.08 -0.09 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):